$0.645
+0.004 (+0.59%)終値時点
価格予想
アプリで開くと、より長期の予想を確認できます。
類似チャート分析による OTLK の予測・予想
Alphio's OTLK stock price prediction model matches the current Outlook Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.65 (+0.12%). The 1-week path is $0.65 (+1.02%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Outlook Therapeutics Inc 株は買うべき？
Outlook Therapeutics Inc (OTLK) is not a strong buy right now due to its current price of $0.6449 and a low RSI of 32.554, indicating oversold conditions. The company has recently received FDA approval for its drug LYTENAVA, which could potentially generate over $500 million in annual sales by 2030, but it also reported a significant net loss of $20.3 million for Q3 2026. The stock has a forward P/E of 2.8498, suggesting potential undervaluation, but the high volatility and negative sentiment surrounding the stock create considerable risk.
OTLK の株価は Friday に $0.64 で引け、その前に上昇 +0.59%
Outlook Therapeutics Inc (OTLK) last closed at $0.6449, gaining +0.59%. These facts feed the 1-day and 1-week OTLK price prediction above.
予想の要因
Outlook Therapeutics Inc（OTLK）の予想は、類似したチャートパターン・季節性・移動平均を組み合わせています。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
類似チャートパターン
直近の値動きが OTLK に最も近い銘柄を、類似度順に表示します。
OTLK の季節性分析
Historically the probability of a positive August return for OTLK is 40.62%. July offers the highest probability of a positive month at 66.67%, while October is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。